WM P5
Alternative Names: WM-P5Latest Information Update: 28 Apr 2025
At a glance
- Originator Well Marker Bio
- Developer Wellmarker Bio
- Class Antineoplastics
- Mechanism of Action Protein-protein interaction modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Colorectal cancer
Most Recent Events
- 28 Apr 2025 No recent reports of development identified for research development in Colorectal-cancer in South Korea
- 10 Mar 2021 Early research in Colorectal cancer in South Korea (unspecified route) (Well Marker Bio pipeline, March 2021)
- 28 Feb 2019 Wellmaker Bio and Korea Institute of Radiological and Medical Sciences signed a mutual co-operation agreement (MOU) for anti-cancer drug development